|
|
 |
|
Viewing report
|
|
|
|
Isis Pharmaceuticals, Inc.
Datamonitor, Sep 2010, Pages: 24
The Isis Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Isis Pharmaceuticals, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Isis Pharmaceuticals (Isis) is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs. The company's principal activity is to develop and market RNA-based drugs for the treatment of cardiovascular diseases, metabolic, inflammatory and cancer diseases. The company primarily operates in the US. Isis is headquartered in Carlsbad, California and employs 250 people. The company recorded revenues of $121.6 million during the financial year (FY) ended December 2009, an increase of 13.4% over FY2008. The increase was primarily due to an increase in revenue from the collaboration with Genzyme and the $10 million sublicensing revenue from OncoGenex. The operating loss of the company was $27.5 million during FY2009, as compared to an operating loss of $13.1 million in FY2008. The net profit was $150.7 million in FY2009, as compared to a net loss of $22.9 million in FY2008.
Scope of the Report
- Provides all the crucial information on Isis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Isis Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Isis Pharmaceuticals, Inc.
-Data is supplemented with details on Isis Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Isis Pharmaceuticals, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Isis Pharmaceuticals, Inc. - SWOT Analysis
Isis Pharmaceuticals, Inc.
Isis Pharmaceuticals, Inc. (ISIS) - Financial and Strategic SWOT Analysis Review
Depomed, Inc.
Enzon Pharmaceuticals, Inc. - SWOT Analysis
King Pharmaceuticals, Inc
Isis Pharmaceuticals, Inc.: SWOT Analysis & Company Profile
Vertex Pharmaceuticals, Inc. - SWOT Analysis
ISTA Pharmaceuticals, Inc. - SWOT Analysis
MDS Inc
|
|
|
|
